Inland Valley Hospice 3770 Myers Street, Riverside, CA, 92503 | |
(951) 360-5848 |
News Archive
In a records review of 290 people at risk for Alzheimer's disease, scientists at Johns Hopkins say they have identified an average level of biological and anatomical brain changes linked to Alzheimer's disease that occur three to 10 years - some even more than 30 years - before the disease's first recognizable symptoms appear.
University of Florida researchers say they are a step closer to a technique to easily detect a wide variety of cancers before symptoms become apparent.
Respicardia®, Inc., a developer of implantable therapies to improve respiratory and cardiovascular health, announced that it has been awarded the U.S. Healthcare Product of the Year by Acquisition International for the remede System, the first and only implantable device for the treatment of central sleep apnea.
New research out of the University of Cincinnati reveals a relatively rare look into the success of substance abuse treatment programs for African-Americans. Researchers report that self-motivation could be an important consideration into deciding on the most effective treatment strategy.
› Verified 8 days ago
Name | Inland Valley Hospice |
---|---|
Location | 3770 Myers Street, Riverside, California |
Hospice ID | 551548 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
Accreditation Provider | The Joint Commission (TJC) |
SSA county code | 430 |
News Archive
In a records review of 290 people at risk for Alzheimer's disease, scientists at Johns Hopkins say they have identified an average level of biological and anatomical brain changes linked to Alzheimer's disease that occur three to 10 years - some even more than 30 years - before the disease's first recognizable symptoms appear.
University of Florida researchers say they are a step closer to a technique to easily detect a wide variety of cancers before symptoms become apparent.
Respicardia®, Inc., a developer of implantable therapies to improve respiratory and cardiovascular health, announced that it has been awarded the U.S. Healthcare Product of the Year by Acquisition International for the remede System, the first and only implantable device for the treatment of central sleep apnea.
New research out of the University of Cincinnati reveals a relatively rare look into the success of substance abuse treatment programs for African-Americans. Researchers report that self-motivation could be an important consideration into deciding on the most effective treatment strategy.
› Verified 8 days ago
NPI Number | 1437157732 |
Organization Name | Inland Valley Hospice |
Address | 3770 Myers St Riverside, California, 92503 |
Phone Number | (951)360-5848 |
News Archive
In a records review of 290 people at risk for Alzheimer's disease, scientists at Johns Hopkins say they have identified an average level of biological and anatomical brain changes linked to Alzheimer's disease that occur three to 10 years - some even more than 30 years - before the disease's first recognizable symptoms appear.
University of Florida researchers say they are a step closer to a technique to easily detect a wide variety of cancers before symptoms become apparent.
Respicardia®, Inc., a developer of implantable therapies to improve respiratory and cardiovascular health, announced that it has been awarded the U.S. Healthcare Product of the Year by Acquisition International for the remede System, the first and only implantable device for the treatment of central sleep apnea.
New research out of the University of Cincinnati reveals a relatively rare look into the success of substance abuse treatment programs for African-Americans. Researchers report that self-motivation could be an important consideration into deciding on the most effective treatment strategy.
› Verified 8 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
In a records review of 290 people at risk for Alzheimer's disease, scientists at Johns Hopkins say they have identified an average level of biological and anatomical brain changes linked to Alzheimer's disease that occur three to 10 years - some even more than 30 years - before the disease's first recognizable symptoms appear.
University of Florida researchers say they are a step closer to a technique to easily detect a wide variety of cancers before symptoms become apparent.
Respicardia®, Inc., a developer of implantable therapies to improve respiratory and cardiovascular health, announced that it has been awarded the U.S. Healthcare Product of the Year by Acquisition International for the remede System, the first and only implantable device for the treatment of central sleep apnea.
New research out of the University of Cincinnati reveals a relatively rare look into the success of substance abuse treatment programs for African-Americans. Researchers report that self-motivation could be an important consideration into deciding on the most effective treatment strategy.
› Verified 8 days ago
Home Health Aides | 13 |
Licensed Practical or Vocational Nurses | 5 |
Medical Social Workers | 2 |
Physicians | 2 |
Registered Nurses | 4 |
Total Employees | 26 |
---|
News Archive
In a records review of 290 people at risk for Alzheimer's disease, scientists at Johns Hopkins say they have identified an average level of biological and anatomical brain changes linked to Alzheimer's disease that occur three to 10 years - some even more than 30 years - before the disease's first recognizable symptoms appear.
University of Florida researchers say they are a step closer to a technique to easily detect a wide variety of cancers before symptoms become apparent.
Respicardia®, Inc., a developer of implantable therapies to improve respiratory and cardiovascular health, announced that it has been awarded the U.S. Healthcare Product of the Year by Acquisition International for the remede System, the first and only implantable device for the treatment of central sleep apnea.
New research out of the University of Cincinnati reveals a relatively rare look into the success of substance abuse treatment programs for African-Americans. Researchers report that self-motivation could be an important consideration into deciding on the most effective treatment strategy.
› Verified 8 days ago
Vitas Healthcare Corporation Of California Location: 7888 Mission Grove Parkway S, Suite 200, Riverside, California, 92508 Phone: (951) 360-5848 |
Ascend Hospice Location: 7344 Magnolia Ave, Ste 245, Riverside, California, 92504 Phone: (951) 360-5848 |
Companion Hospice, Llc Location: 4199 Flat Rock Drive, Suite 200, Riverside, California, 92505 Phone: (951) 360-5848 |
Inland Valley Hospice Location: 3770 Myers Street, Riverside, California, 92503 Phone: (951) 360-5848 |